Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus
暂无分享,去创建一个
J. Audet | D. Kobasa | A. Leung | B. Griffin | Nikesh Tailor | Kevin Tierney | Mable Chan | Robert Vendramelli | M. Chan | Anders Leung
[1] O. Dyer. Two Ebola treatments halve deaths in trial in DRC outbreak , 2019, BMJ.
[2] A. Maxmen. Two Ebola drugs show promise amid ongoing outbreak. , 2019, Nature.
[3] D. Watson-Jones,et al. Prevention of Ebola virus disease through vaccination: where we are in 2018 , 2018, The Lancet.
[4] M. Aman,et al. Efficacy of Ebola Glycoprotein-Specific Equine Polyclonal Antibody Product Against Lethal Ebola Virus Infection in Guinea Pigs. , 2018, The Journal of infectious diseases.
[5] X. Qiu,et al. The Makona Variant of Ebola Virus Is Highly Lethal to Immunocompromised Mice and Immunocompetent Ferrets. , 2018, The Journal of infectious diseases.
[6] T. Nyenswah,et al. Recently Identified Mutations in the Ebola Virus-Makona Genome Do Not Alter Pathogenicity in Animal Models. , 2018, Cell reports.
[7] X. Qiu,et al. Development and characterization of a guinea pig model for Marburg virus , 2018, Zoological research.
[8] P. Formenty,et al. Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors — Final Report , 2017, The New England journal of medicine.
[9] Marisa C St Claire,et al. Animal Models of Ebolavirus Infection. , 2017, Comparative medicine.
[10] N. Loman,et al. Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to Child , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Michael A Proschan,et al. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. , 2016, The New England journal of medicine.
[12] Ian Goodfellow,et al. Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] H. Ebihara,et al. Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis. , 2016, Journal of molecular biology.
[14] M. Ramakrishnan. Determination of 50% endpoint titer using a simple formula. , 2016, World journal of virology.
[15] Jeffrey R. Kugelman,et al. Molecular Evidence of Sexual Transmission of Ebola Virus. , 2015, The New England journal of medicine.
[16] X. Qiu,et al. Development and Characterization of a Guinea Pig-Adapted Sudan Virus , 2015, Journal of Virology.
[17] Justine R. Smith,et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. , 2015, The New England journal of medicine.
[18] Samantha E. Zak,et al. Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease. , 2015, The Journal of infectious diseases.
[19] C. Basler. Innate immune evasion by filoviruses. , 2015, Virology.
[20] Jeffrey M. Weiss,et al. Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance , 2014, Science.
[21] D. Huson,et al. Fast and sensitive protein alignment using DIAMOND , 2014, Nature Methods.
[22] Stephan Günther,et al. Emergence of Zaire Ebola virus disease in Guinea. , 2014, The New England journal of medicine.
[23] Michael McCarthy,et al. US signs contract with ZMapp maker to accelerate development of the Ebola drug , 2014, BMJ : British Medical Journal.
[24] J. Strong,et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™ , 2014, Nature.
[25] X. Qiu,et al. Establishment and Characterization of a Lethal Mouse Model for the Angola Strain of Marburg Virus , 2014, Journal of Virology.
[26] L. Glenn. Ebola in the Democratic Republic of the Congo , 2012 .
[27] X. Qiu,et al. Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies , 2012, Science Translational Medicine.
[28] Sergey I. Nikolenko,et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..
[29] L. Hensley,et al. Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. , 2011, The Journal of infectious diseases.
[30] Steven B. Bradfute,et al. Filovirus infection of STAT-1 knockout mice. , 2011, The Journal of infectious diseases.
[31] Steven B. Bradfute,et al. Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever , 2009, Journal of Virology.
[32] Steven B. Bradfute,et al. Lymphocyte death in a mouse model of Ebola virus infection. , 2007, The Journal of infectious diseases.
[33] C. Basler,et al. Ebola Virus VP24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin α Proteins with Activated STAT1 , 2007, Journal of Virology.
[34] G. Neumann,et al. Molecular Determinants of Ebola Virus Virulence in Mice , 2006, PLoS pathogens.
[35] V. Volchkov,et al. Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation , 2006, Journal of Virology.
[36] P. Jahrling,et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys , 2003, The Lancet.
[37] P. Jahrling,et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. , 2003, The American journal of pathology.
[38] G. Nabel,et al. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. , 2002, Molecular cell.
[39] M. Bray,et al. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. , 2001, Journal of comparative pathology.
[40] M. Bray,et al. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. , 2001, Journal of comparative pathology.
[41] M. Bray. The role of the Type I interferon response in the resistance of mice to filovirus infection. , 2001, The Journal of general virology.
[42] H. Feldmann,et al. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages , 1996, Journal of virology.
[43] P. Jahrling,et al. Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. , 1992, Journal of comparative pathology.
[44] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .
[45] Jeffrey E. Barrick,et al. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. , 2014, Methods in molecular biology.
[46] V. Volchkov,et al. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. , 2006, Journal of virology.
[47] M. Bray,et al. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. , 1998, The Journal of infectious diseases.